Mountain View, CA, United States of America

Vijay Singh


 

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Vijay Singh: Innovator in Oligonucleotide Probe Technology

Introduction

Vijay Singh is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of oligonucleotide probe technology, holding 2 patents that showcase his innovative approaches.

Latest Patents

His latest patents include the "Probe inversion process for in situ synthesized probe arrays." This patent relates to processes for inverting oligonucleotide probes in an in situ synthesized array. These processes can reverse the orientation of probes with respect to the substrate from 3'-bound to 5'-bound. Additionally, these processes can reduce or eliminate the presence of truncated probe sequences from an in situ synthesized array. Another patent, "Oligonucleotide probe inversion process for in situ synthesized probe arrays," shares similar objectives and methodologies, further emphasizing his expertise in this area.

Career Highlights

Vijay Singh is currently associated with Centrillion Technology Holdings Corporation, where he continues to advance his research and development efforts. His work has been instrumental in enhancing the capabilities of probe arrays, which are crucial for various applications in genomics and molecular biology.

Collaborations

Some of his notable coworkers include Glenn H McGall and Wei Zhou, who contribute to the collaborative environment that fosters innovation at Centrillion Technology Holdings Corporation.

Conclusion

Vijay Singh's contributions to oligonucleotide probe technology through his patents and work at Centrillion Technology Holdings Corporation highlight his role as a key innovator in the field. His ongoing research promises to further enhance the capabilities of probe arrays, making significant impacts in scientific research and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…